Breaking News

You are here » Indian-Commodity  :  Commodities  :  Rubber  :  Physical rubber prices ruled steady on Wednesday

26-Apr2018

Physical rubber prices ruled steady on Wednesday

Physical rubber prices ruled steady on Wednesday. Spot prices for RSS-4 and RSS-5 variety closed unchanged at Rs 119/ kg and Rs 117/ kg respectively.

In the futures market, May delivery gained marginally to Rs 120.92 compared to its previous closing of Rs 120.45, while June delivery closed at Rs 123.79 compared to its previous close of Rs 122.94 on the National Multi Commodity Exchange (NMCE).


Related News

View all news

Physical Rubber prices extend weakness on Wednesday

Physical Rubber prices extended weakness on Wednesday amid import rumours as major consuming industries might stay back from the domestic markets in the days ahead.Spot prices for RSS-4 variety fell to......

Physical Rubber prices extend weakness on Tuesday

Physical Rubber prices extended weakness on Tuesday amidst extremely dull volumes in the market. The market managed to sustain at the prevailing levels on enquiries from the tyre sector.Spot prices for......

Physical Rubber prices extend weakness on Tuesday

Physical Rubber prices extended weakness on Tuesday amidst extremely dull volumes in the market. The market managed to sustain at the prevailing levels on enquiries from the tyre sector.Spot prices for......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......